128 related articles for article (PubMed ID: 35774119)
1. Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms.
Ip A; Della Pia A; Kim GYG; Lofters J; Behrmann J; Patel D; Kats S; Estella JJ; De Dios I; Ma W; Pecora AL; Goy AH; Koprivnikar J; McCloskey JK; Albitar M
Front Oncol; 2022; 12():923809. PubMed ID: 35774119
[TBL] [Abstract][Full Text] [Related]
2. Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA.
Garcia-Gisbert N; Garcia-Ávila S; Merchán B; Salido M; Fernández-Rodríguez C; Gibert J; Fernández-Ibarrondo L; Camacho L; Lafuente M; Longarón R; Espinet B; Vélez P; Pujol RM; Andrade-Campos M; Arenillas L; Salar A; Calvo X; Besses C; Bellosillo B
Blood Adv; 2022 May; 6(10):3178-3188. PubMed ID: 35192693
[TBL] [Abstract][Full Text] [Related]
3. Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations.
Chicano M; Carbonell D; Suárez-González J; Lois S; Ballesteros-Culebras M; Andrés-Zayas C; Muñiz P; Rodríguez-Macias G; Bastos-Oreiro M; Font P; Ballesteros M; Kwon M; Anguita J; Díez-Martín JL; Buño I; Martínez-Laperche C
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203905
[TBL] [Abstract][Full Text] [Related]
4. Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors.
Albitar M; Zhang H; Charifa A; Ip A; Ma W; McCloskey J; Donato M; Siegel D; Waintraub S; Gutierrez M; Pecora A; Goy A
Heliyon; 2023 May; 9(5):e16261. PubMed ID: 37251903
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies.
Jiang L; Pallavajjala A; Huang J; Haley L; Morsberger L; Stinnett V; Hardy M; Park R; Ament C; Finch A; Shane A; Parish R; Nozari A; Long P; Adams E; Smith K; Parimi V; Dougaparsad S; Long L; Gocke CD; Zou YS
J Mol Diagn; 2021 Apr; 23(4):467-483. PubMed ID: 33577993
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
Yao R; Yu T; Qing Y; Wang J; Shen Y
Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
[TBL] [Abstract][Full Text] [Related]
7. Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study.
Smyth LM; Reichel JB; Tang J; Patel JAA; Meng F; Selcuklu DS; Houck-Loomis B; You D; Samoila A; Schiavon G; Li BT; Razavi P; Piscuoglio S; Reis-Filho JS; Taylor BS; Baselga J; Solit DB; Hyman DM; Berger MF; Chandarlapaty S
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250397
[TBL] [Abstract][Full Text] [Related]
8. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
[TBL] [Abstract][Full Text] [Related]
9. Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy.
Shen W; Szankasi P; Sederberg M; Schumacher J; Frizzell KA; Gee EP; Patel JL; South ST; Xu X; Kelley TW
Br J Haematol; 2016 Apr; 173(1):49-58. PubMed ID: 26728869
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations.
Iwama E; Sakai K; Azuma K; Harada T; Harada D; Nosaki K; Hotta K; Ohyanagi F; Kurata T; Fukuhara T; Akamatsu H; Goto K; Shimose T; Kishimoto J; Nakanishi Y; Nishio K; Okamoto I
Ann Oncol; 2017 Jan; 28(1):136-141. PubMed ID: 28177428
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing.
Guo Q; Wang J; Xiao J; Wang L; Hu X; Yu W; Song G; Lou J; Chen J
Mol Cancer; 2018 Aug; 17(1):131. PubMed ID: 30153823
[TBL] [Abstract][Full Text] [Related]
12. A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid Neoplasms.
Liquori A; Lesende I; Palomo L; Avetisyan G; Ibáñez M; González-Romero E; Boluda-Navarro M; Morote-Faubel M; Garcia-Ruiz C; Martinez-Valiente C; Santiago-Balsera M; Gomez-Seguí I; Sanjuan-Pla A; Sanz MA; Sanz G; Solé F; Such E; Cervera J
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919541
[TBL] [Abstract][Full Text] [Related]
13. Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?
Kawata E; Hedley BD; Chin-Yee B; Xenocostas A; Lazo-Langner A; Hsia CC; Howson-Jan K; Yang P; Levy MA; Santos S; Bhai P; Howlett C; Lin H; Kadour M; Sadikovic B; Chin-Yee I
Int J Lab Hematol; 2022 Apr; 44(2):333-341. PubMed ID: 34713980
[TBL] [Abstract][Full Text] [Related]
14. Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms.
Sadato D; Hirama C; Kaiho-Soma A; Yamaguchi A; Kogure H; Takakuwa S; Ogawa M; Doki N; Ohashi K; Harada H; Oboki K; Harada Y
PLoS One; 2021; 16(7):e0255257. PubMed ID: 34297770
[TBL] [Abstract][Full Text] [Related]
15. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing for tumor mutation quantification using liquid biopsies.
Provencio M; Pérez-Barrios C; Barquin M; Calvo V; Franco F; Sánchez E; Sánchez R; Marsden D; Cristóbal Sánchez J; Martin Acosta P; Laza-Briviesca R; Cruz-Bermúdez A; Romero A
Clin Chem Lab Med; 2020 Jan; 58(2):306-313. PubMed ID: 31469650
[TBL] [Abstract][Full Text] [Related]
17. Detection of genome-wide copy number variants in myeloid malignancies using next-generation sequencing.
Shen W; Paxton CN; Szankasi P; Longhurst M; Schumacher JA; Frizzell KA; Sorrells SM; Clayton AL; Jattani RP; Patel JL; Toydemir R; Kelley TW; Xu X
J Clin Pathol; 2018 Apr; 71(4):372-378. PubMed ID: 29197855
[TBL] [Abstract][Full Text] [Related]
18. Targeted Next-Generation Sequencing of Circulating Tumor DNA, Bone Marrow, and Peripheral Blood Mononuclear Cells in Pediatric AML.
Ruan M; Liu L; Qi B; Chen X; Chang L; Zhang A; Liu F; Wang S; Liu X; Chen X; Zhang L; Guo Y; Zou Y; Zhang Y; Chen Y; Liu L; Cao S; Lou F; Wang C; Zhu X
Front Oncol; 2021; 11():666470. PubMed ID: 34422630
[TBL] [Abstract][Full Text] [Related]
19. Analyzing microsatellite instability and gene mutation in circulating cell-free DNA to monitor colorectal cancer progression.
Fu Y; Ye Y; Liu X; Zhu G; Xu Y; Sun J; Wu H; Feng F; Wen Z; Jiang S; Li Y; Zhang Q
Transl Cancer Res; 2021 Jun; 10(6):2812-2821. PubMed ID: 35116591
[TBL] [Abstract][Full Text] [Related]
20. Liquid biopsies using pleural effusion-derived exosomal DNA in advanced lung adenocarcinoma.
Song Z; Cai Z; Yan J; Shao YW; Zhang Y
Transl Lung Cancer Res; 2019 Aug; 8(4):392-400. PubMed ID: 31555514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]